Celldex Therapeutics Inc (NASDAQ:CLDX)

2.36
Delayed Data
As of Feb 22
 -0.06 / -2.48%
Today’s Change
2.20
Today|||52-Week Range
3.94
-16.90%
Year-to-Date
No recent news for Celldex Therapeutics Inc.

Today’s Trading

Previous close2.42
Today’s open2.44
Day’s range2.35 - 2.46
Volume1,216,761
Average volume (3 months)1,207,262
Market cap$329.1M
Data as of 4:00pm ET, 02/22/2018

Growth & Valuation

Earnings growth (last year)+3.05%
Earnings growth (this year)+24.97%
Earnings growth (next 5 years)--
Revenue growth (last year)+23.83%
P/E ratioNM
Price/Sales52.96
Price/Book1.10

Competitors

 Today’s
change
Today’s
% change
VCYTVeracyte Inc-0.01-0.18%
OXFDOxford Immunotec Glo...+0.07+0.59%
QTNTQuotient Ltd+0.01+0.22%
TRIBTrinity Biotech PLC+0.04+0.72%
Data as of 4:00pm ET, 02/22/2018

Financials

Last reporting date--
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$6.8M
Annual profit (last year)-$128.5M
Net profit margin-1,894.05%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Anthony S. Marucci
Chief Financial Officer &
Senior Vice President
Sam Martin
Corporate headquarters
Hampton, New Jersey

Forecasts